Dynavax Technologies Corp
featured
It’s time for the Lightning Round. Cramer makes the call on viewer favorites.
» Read MoreMore
-
Dynavax Technologies Corp.: Approximately 27,594,200 shares changed hands, a 1,322.7 percent increase over its 65- day average volume. The shares fell $1.07 or 43.3 percent to $1.40. Edgewater Technology Inc.: Approximately 279,400 shares changed hands, a 1,695.7 percent increase over its 65- day average volume.
-
Cisco Systems Inc. fell. 5 percent to $24.36 with 59,945,900 shares traded. Comcast Corp. fell. 9 percent to $40.79 with 16,823,200 shares traded. Dynavax Technologies Corp. fell 37.2 percent to $1.55 with 14,965,000 shares traded.
-
NEW YORK-- Dynavax Technologies Corp. said Monday that the Food and Drug Administration wants it to run a new safety study on its hepatitis B vaccine Heplisav, and the company's shares fell almost 30 percent in morning trading. Dynavax said the FDA wants it to get safety data from more patients.
Most Popular Video
No reason has been given yet for the departure of founder and executive chairman George Zimmer, reports CNBC's Courtney Reagan. Zimmer has long been the face of the company.
Wednesday, 19 Jun 2013 | 10:52 AM ETCNBC's Rick Santelli, explains why he hears 'crickets" when he asks questions about Fed Chairman Bernanke's policies. "Enough is enough," he rants.
Wednesday, 19 Jun 2013 | 11:36 AM ETAre reporters lobbing "softball" questions at the Fed chairman? CNBC's Rick Santelli and the Wall Street Journal's Jon Hilsenrath, debate whether the economy continues to need quantitative easing. I'm trying to inform the public about what the Fed is up to, says Hilsenrath.